Tag archive for ‘Glenmark Pharmaceuticals receives ANDA approval for Sirolimus Tablets’
By editor3 On Monday, October 19th, 2020
0 Comments

Glenmark Pharmaceuticals receives ANDA approval for Sirolimus Tablets, 0.5 mg, 1 mg and 2 mg

Mumbai, October 19, 2020. Glenmark Pharmaceuticals Inc., USA (Glenmark) has received final approval by the United States Food & Drug Administration (U.S. FDA) for Sirolimus Tablets, 0.5 mg, 1 mg and 2 mg, More...

Live Updates COVID-19 CASES